TNF and inflammatory bowel disease: Anti-TNFα therapies are highly effective agents for the treatment of IBD, and include Infliximab (UC, CD), Adalimumab (UC, CD), Golimumab (UC) and Certolizumab (CD in US and selected European countries only) [9].